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Hydrophobically modified (hm) derivatives of biopolymers such as chitosan have 
been shown to convert liquid blood into an elastic gel. This interesting material property 
could make hm-chitosan (hmC) useful as a hemostatic agent in treating severe bleeding. 
In this work, we attempted to probe the mechanism of action of hmC by studies on 
mixtures of blood cells and hmC using optical microscopy. Our results show that the 
presence of hydrophobic tails on hmC induces significant clustering of blood cells. We 
show that clustering increases as the fraction of hydrophobic tails on hmC increases, 
length of the hydrophobic tails increases, and as concentration of hmC increases. Finally, 
clustering due to hmC could be reversed by the addition of the supramolecule -
cyclodextrin, which is known to capture hydrophobes in its binding pocket. The results 
from this work support the earlier mechanism, with a few important modifications.    
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Chapter 1: INTRODUCTION & OVERVIEW 
 
 
The motivation for the current work comes from recent studies that have been 
published on a class of polymers called “associating” polymers. These are polymers that 
have a hydrophilic backbone and hydrophobic side-chains (“tails”) that are tethered to the 
backbone.1,2 The hydrophobic tails on adjacent polymer chains will tend to associate with 
each other via hydrophobic interactions, and as a result, these polymers have the ability to 
thicken aqueous solutions.1,3 Moreover, these polymers also tend to have strong 
interactions with different types of colloidal and self-assembled structures.1,2,4-13  
 
In our laboratory, we have focused on associating polymers derived by attaching 
hydrophobic tails to common biopolymers such as chitosan and alginate. Much of our 
work has been done with chitosan, which is a cationic polysaccharide that is itself derived 
from chitin. Chitin is the second most abundant biopolymer in nature following cellulose, 
and it is found in the hard shells of insects and crustaceans like crabs and shrimp.14 While 
chitin is insoluble in water, it can be deacetylated to give chitosan, which is soluble under 
acidic conditions due to the presence of charged amine groups. We convert chitosan into 
an associating polymer by attaching n-alkyl tails to some of the amines along the polymer 
backbone.9,10,12,13,15 The resulting polymer is termed hydrophobically modified chitosan 
(hmC).    
 
We have studied hmC in conjunction with structures covered by lipid membranes, 
including vesicles and biological cells.9,10,12,13,15 First, we showed that when hmC was 
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added to a solution of vesicles (~ 100 nm in diameter), the thin liquid was converted into 
an elastic gel.13 Thereafter, we demonstrated similar gelation when hmC was mixed with 
liquid blood (either human or bovine).10 Gelation was confirmed by rheological 
techniques (Figure 1.1). Note that blood cells are several microns in diameter, i.e., they 
are much larger than the vesicles. Also, it is important to mention that we added heparin 
or sodium citrate to the blood to prevent its coagulation via the blood clotting cascade. 
Thus, gelation of blood by hmC was not related to biochemical pathways. We also 
showed that gelation by hmC required the presence of the blood cells; in contrast, 
gelation did not occur when hmC was added to the protein component of blood, i.e., 
blood plasma. Moreover, hmC also gelled other kinds of biological cells including 





Figure 1.1 Visual observations and rheological data showing that hmC gels blood 
whereas chitosan does not. Here, hmC and chitosan (0.25 wt%) are added to heparinized 
human blood. The hmC /blood mixture holds its weight in the inverted tube whereas the 
chitosan/blood mixture is a freely flowing liquid. In (a) dynamic rheological data for the 
elastic modulus G and the viscous modulus G vs. frequency  are shown for the two 
samples. The hmC sample (closed symbols) displays the rheology of a gel (G > G) 
 3 
whereas the chitosan sample (open symbols) responds like a viscous sol. In (b) steady-
shear rheological data for the viscosity vs. shear stress are shown. The hmC/blood 
mixture (red circles) shows a significantly higher viscosity relative to both the 
chitosan/blood mixture (yellow triangles) as well as a 0.25 wt% solution of hmC alone.    
 
 The mechanism for the gelation of microscale cells of blood (as well as nanoscale 
vesicles) by hmC has been hypothesized to involve hydrophobic interactions.10,13 
Specifically, some of the hydrophobic tails on hmC are expected to get inserted into the 
membranes of blood cells. Thereby, the same hmC chain could become bound to more 
than one cell, i.e., the chain could bridge adjacent cells. Such bridging would result in a 
sample-spanning three-dimensional (3-D) network of cells connected by polymer chains 
(see Figure 2.2 in Chapter 2), which can explain the gel-like behavior of the sample.  
 
Support for the above mechanism comes from various related experiments. For 
example, other associating polymers, including hydrophobically modified alginate 
(hmA), hydrophobically modified polyethylene oxide (hm-PEO), and hydrophobically 
modified hydroxyethylcellulose (hm-HEC) have also been shown to form gels when 
mixed with blood, other cells, or vesicles.15-19 Moreover, our laboratory has shown that 
gelation of blood (or vesicles) by hmC can be reversed by adding alpha-cyclodextrin 
(-CD), a barrel-shaped supramolecule with a hydrophobic binding pocket.10,15 Such 
reversal is hypothesized to occur because -CD molecules can sequester the hydrophobes 
on hmC within their binding pockets, thereby preventing the chains from connecting 
adjacent cells. Thus, the very fact that -CD works as an ungelling agent points to 
hydrophobic interactions as being responsible for gelation in the first place.   
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The gelling of blood by hmC is not just of academic interest. This property 
suggests that hmC could serve as a hemostatic agent and prevent bleeding from traumatic 
injuries. Traumatic injury is a significant source of mortality worldwide with an 
estimated rate of 70 per 100,000 of the population in 2013.20 In the US, trauma is now the 
leading cause of death for those 46 and under.21 A major cause of these trauma deaths is 
uncontrolled hemorrhage in both the civilian and military arena.22-26 To test the 
hemostatic ability of hmC, we collaborated with surgeons at the University of Maryland 
Medical School. We showed that hmC-based solid dressings can arrest even the most 
severe of bleeds (such as injuries to the femoral artery in pigs) whereas native chitosan 
was unable to contain the same bleeds.27 In addition, hmC-based foams have also been 
shown to act as hemostatic agents against liver injuries in pigs.28,29 Thus, hmC has 
significant potential as a hemostatic agent.  
 
Although the exact mechanism for hemostatic action by hmC-based dressings and 
foams is still not understood, we believe it is at least partly connected to the blood-gelling 
ability of hmC. This brings us to the mechanism for blood gelling. While the postulated 
mechanism (in terms of hydrophobic interactions) is reasonable, the evidence for it has 
been mostly indirect. There is still a need to substantiate this mechanism by directly 
probing the microstructure in hmC-blood mixtures. Since blood cells are microscale 
structures, they can be directly visualized by optical microscopy. We therefore set out to 
study the interactions between blood cells and hmC using bright-field optical microscopy. 
Results for hmC are compared with those for the parent chitosan. Important variables in 
our study include the degree of hydrophobic modification, the polymer molecular-weight, 
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and the polymer concentration. In addition, we also study hmC-blood mixtures after the 
addition of various cyclodextrins. Overall, the results from this work support the earlier 
mechanism, but they do suggest a few important modifications. 
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Chapter 2: BACKGROUND 
 
2.1 Chitosan 
 Chitosan is a linear polysaccharide that is derived from chitin (poly-N-acetyl-
glucosamine) (structure in Figure 2.1a). To produce chitosan, chitin is first extracted from 
the shells of crustaceans such as crabs and shrimp. Then chitin is deacetylated under 
basic conditions to give chitosan. Deacetylation is usually incomplete, leaving a small 
percentage of the N-acetyl groups along the polymer backbone. The number of remaining 
N-acetyl groups remaining on chitosan is expressed as degree of acetylation (DA). DA is 
the percentage of glucosamine units that are still bound to an N-acetyl group. DA values 
of commercially available chitosans typically range from 30% down to 1%.30-32  The 
structure of chitosan is shown below, along with a schematic representation. (Figure 2.1). 
To dissolve chitosan in an aqueous solution, the amines along its backbone need to be 
protonated. Thus, a pH below 6.5 is required for chitosan to be soluble. Many acids can 
be used to achieve this pH, with acetic acid being the most common choice. When the 






Figure 2.1 Chemical structure of (a) chitosan and (b) hydrophobically modified chitosan 




Chitosan has many interesting and useful properties. It is currently used 
commercially in a variety of applications, including water treatment, food preservation, 
dietary pills and supplements, antibacterial coatings, and bioseparation membranes. 14,30 
Also, it is considered biocompatible and has been used in medical applications such as 
drug delivery, tissue engineering, and wound care. 30,33 Chitosan also has antimicrobial 
properties and has been shown to be effective against a range of bacteria. 31,34 Chitosan is 
also used extensively in hemostatic products. It is thought that chitosan acts as a 
mucoadhesive, which creates a mechanical barrier at the injury site, thus reducing blood 
loss from the wound and helping the body form a natural clot to fully stop the bleeding.35 
However, the hemostatic efficacy of native chitosan has been called into question in 
several studies, including ours.27-29   
 
2.2 Hydrophobically Modified Chitosan 
 Hydrophobically modified chitosan (hmC) is produced by reacting aldehydes with 
the amine groups on chitosan via reductive amination.10,13 In the process, the amine 
(NH2) groups are converted into NH-R groups, where R is the moiety attached to the 
aldehyde.  Typically, R is an n-alkyl moiety ranging from C6 to C12. The structure of 
hmC with C12 hydrophobic tails is shown in Figure 2.1b. A typical procedure for 
synthesizing hmC with C12 tails involves the following steps. First, n-dodecyl aldehyde is 
added to an acidic chitosan solution in a water-ethanol mixture, followed by addition of 
sodium cyanoborohydride. The molar ratio of aldehyde to chitosan monomer(s) is fixed 
at a certain value (e.g. 2.5%). The reaction yields the hmC, which is then precipitated by 
raising the pH and adding ethanol. Next, the precipitate is purified by washing with 
 8 
ethanol followed by deionized water. The final hmC precipitate is re-dissolved in acetic 
acid solution and the concentration is recalibrated. This solution tends to be viscous due 
to associations between the hydrophobes (this is a qualitative indication that the synthesis 
has been successful). The degree of hydrophobic modification (i.e., the amines with a 
hydrophobic unit divided by the total available amines) tracks the value expected from 
stoichiometry, and this can be confirmed using 1H NMR. Typical levels of modification 















Figure 2.2 Photographs of gels obtained by combining hmC with (a) vesicles; and (b) 
citrated bovine blood. In both cases, the gels hold their weight in the inverted vials. 
Schematics of the microstructure in each gel is also shown. It is hypothesized that the 
hmC chains insert their hydrophobes into the membranes of vesicles or blood cells, 




2.3 Studies on hmC Combined with Vesicles, Blood, Mammalian Cells 
Our lab has previously shown that a gel is formed when a solution of hmC is 
mixed with a solution of cationic surfactant vesicles.13  Examination of the resulting gels 
using small-angle neutron scattering and cryo-TEM confirms that the vesicles remain 
intact during the formation of the gel.  Based on both these findings and the observation 
that unmodified chitosan does not form a similar gel with the vesicles, it was 
hypothesized that the mechanism for gelation between hmC and cationic vesicles 
involves insertion of the hydrophobic groups on the hmC backbone into the vesicle 
bilayers.  This creates a 3-dimensionally crosslinked network that immobilizes the hmC 
polymer chains and results in an elastic gel.  A picture of a typical hmC/vesicle gel and a 
schematic representation of the gel network is shown above in figure 2.2(a).13  
 
In addition our lab has previously reported that when hmC is mixed with blood, 
the mixture also forms a gel.10  In contrast, unmodified chitosan does not result in 
gelation when mixed with blood.  We previously proposed a mechanism for the gelation 
of hmC with blood which paralleled that proposed for vesicles.  This mechanism is that 
the hydrophobic groups from hmC insert themselves into the blood cell membranes 
forming a network of crosslinks as shown above in figure 2.2(b).10  
 
The gelation properties of hmC can be extended to cell types other than blood 
cells, as shown by Javvaji et. al.15  In this work, suspensions of human MCF7 breast 
cancer cells and human umbilical vein endothelial cells (HUVECs) were gelled by 
mixing with solutions of hmC.  The reported rheological profile of the cell/hmC gels 
showed very similar characteristics to the data with bloods cells shown in figure 1.1.  
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This ability to gel various types of cells could have important applications in fields such 
as tissue engineering and cell culture.   
 
Interestingly, the gelation of vesicles, blood cells, and mammalian cells can all be 
reversed by the addition of a molecule called alpha-cyclodextrin (-CD).10,15  Upon 
addition of -CD, the mixtures will once again become free-flowing liquids. -CD is a 
largely hydrophilic molecule, but it uniquely contains a small hydrophobic inner pocket.   
We have previously suggested that reversal of gelation is due to the hydrophobes on the 
hmC being sequestered into the hydrophobic pockets of the -CD molecules.  Such 
sequestration consequently displaces the hydrophobes from the bilayers and reverses the 
physical gelation.  A schematic of this process is shown below in figure 2.3. 
 
 
Figure 2.3 Schematic mechanism of ungelling induced by -CD: the hydrophobes on the 
polymer are disengaged from cell membranes and instead sequestered within the 
hydrophobic cavities of the -CDs. 
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2.4 Optical Microscopy and Image Analysis  
The main technique used in this work is bright-field optical microscopy.  
Microscopy is a technique used to visualize things that are below the resolution of the 
human eye using optical lenses for magnification.  Microscopes work by focusing light 
through a series of lenses, resulting magnifications of 100x to over 1000x.  There is a 
limit to the magnifying ability of microscopes, however, as the diffraction of light 
through the microscope’s aperture becomes significant as the size of the object being 
observed approaches the wavelength of the light being used to see it.36 
 
Sample contrast is an important factor in microscopic imaging.  Samples that 
exhibit strong contrast against their surroundings can be easily imaged using standard 
bright field microscopy in which light is transmitted through the sample, and the sample’s 
contrast relative to the background makes it clearly visible.  In the case of highly 
translucent samples which exhibit poor contrast, a technique known as phase contrast 
enhancement may be employed.  This technique separately manipulates the transmitted 
and scattered light to artificially enhance contrast.36,37   
 
Once microscopic images are collected, the images may need to be systematically 
analyzed to extract quantitative data related to the sample. The process for obtaining data 
from images is known as image analysis.  The basic goal of image analysis is primarily to 
count and measure objects (such as particles or biological cells) that are present in a 
microscopic image.  This involves the recognition by the software of each individual 
object’s size and shape.37    
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Image analysis can be performed using a series of steps.  The first steps are 
visualization on a microscope, and image capture by an associated camera.  The resulting 
image is then processed by converting to grey scale (if not already captured in grey 
scale), segmentation of the various particles in the image, and binary processing in which 
data is generated based on the particles in the image.  The measurements are reported as 
numerical data, which can then be analyzed and interpreted as appropriate for the 
particular sample type under investigation.  This process is represented schematically by 
the following figure 2.4 taken from Pons and Vivier.37 
 
 
Figure 2.4 The flow of the image analysis process 
  
2.5 Rheology  
A second technique used in this thesis is rheology. Rheology is formally defined 
as the study of flow and deformation in materials. Rheological measurements provide 
information on the relation between microstructure and macroscopic properties. These 
measurements are typically performed on a rheometer under steady or dynamic 
oscillatory shear. Typical geometries used in rheometers are the cone-and-plate, the 
parallel plate, and the concentric cylinder or Couette. 
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In steady shear rheology, the sample is subjected to a constant shear-rate   (e.g. 
by applying a continuous rotation at a fixed rate on a rotational instrument), and the 
response is measured as a shear-stress . The ratio of shear-stress  to shear-rate   is the 
(apparent) viscosity . A plot of the viscosity vs. shear-rate   is called the flow curve of 
the material.  
 
In dynamic or oscillatory rheology, a sinusoidal strain 0 sin( )t   is imposed 
on the sample. Here, 0 is the strain-amplitude (i.e. the maximum applied deformation) 
and  is the frequency of the oscillations. The sample response will be in the form of a 
sinusoidal stress 0 sin( )t      which will be shifted by a phase angle  with respect 
to the strain waveform. Using trigonometric identities, this stress waveform can be 
decomposed into two components, one in-phase with the strain and the other out-of-phase 
by 90°: 
 0 0sin( ) cos( )G t G t         (2.1) 
 Here, G′ is the elastic modulus and it provides information about the elastic nature 
of the material. Since elastic behavior implies the storage of deformational energy, G′ is 
also called the storage modulus. On the other hand, G″ is the viscous modulus and it 
characterizes the viscous nature of the material. Since viscous deformation results in the 
dissipation of energy, G″ is also called the loss modulus. For these properties to be 
meaningful, the dynamic measurements must be made in the “linear viscoelastic” (LVE) 
regime of the sample. This means that the stress must be linearly proportional to the 
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imposed strain (i.e., moduli independent of strain amplitude). In that case, the elastic and 
viscous moduli are only functions of the frequency of oscillations , and are true material 
functions. A log-log plot of the moduli vs. frequency, i.e. G() and G″(), is called the 




Chapter 3: INVESTIGATING THE INTERACTIONS BETWEEN 




The goal of this thesis is to study the interactions between hydrophobically 
modified chitosan (hmC) and blood using bright-field optical microscopy. As mentioned 
previously, hmC has been shown to convert liquid blood into a gel, and the mechanism is 
believed to involve hydrophobic interactions.10 That is, hydrophobes on hmC are 
believed to embed in the membranes of blood cells, thereby connecting adjacent cells into 
a 3-D network (see schematic in Figure 2.2b). Thus far, no direct evidence for this 
mechanism has been obtained, i.e., there have been no direct or in situ studies into the 
microstructure of hmC/blood mixtures.  
 
Blood is a combination of different cell types (red cells, white cells, platelets), but 
the red blood cells (RBCs) are by far the most abundant and these typically have 
diameters of about 6-8 µm.38 Thus, blood cells can be directly visualized by optical 
microscopy. In our experiments, we add hmC to blood and observe the mixtures under 
the microscope for distinct perceptible changes. Our principal finding is that hmC 
induces blood cells to aggregate into large clusters. We correlate the extent of clustering 
as a function of different variables including the degree of hydrophobic modification of 
the hmC, the hmC molecular-weight, and the hmC concentration. In addition, we also 
study hmC-blood mixtures after the addition of various cyclodextrins (CDs) to probe 
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whether the CDs have an effect on the extent of clustering. Overall our work provides 
further insight into hmC/blood interactions and this leads us to propose a few 




Materials. Chitosan (99% deacetylated) was purchased from Primex (Iceland).  Dodecyl 
aldehyde and sodium cyanoborohydride were obtained from Sigma Aldrich. Alpha-
cyclodextrin (-CD), methyl-beta-cyclodextrin (m-CD), and hydroxypropyl-beta-
cyclodextrin (hp-CD) were obtained from TCI America. Citrated bovine whole blood 
was obtained from Lampire Biological Laboratories. Mouse fibroblast L929 cells were 
obtained from ATCC, as were reagents for cell culture, including Eagle’s MEM culture 
media, fetal bovine serum (FBS), and penicillin-streptomycin solution.  
 
Synthesis. hmC was synthesized using a procedure based on previous methods.10,13 
Briefly, chitosan was dissolved at 1% w/v in a 0.2 M acetic acid solution. An equal 
volume of ethanol was then added as a co-solvent before the temperature was increased 
to 55°C.   Varying amounts of n-alkyl aldehyde were dissolved in ethanol and mixed into 
the chitosan solution to give varying levels of hydrophobic modification (0.5, 1.0, 2.0, 5.0 
mol%, relative to the amines). The reaction mixture was treated with an aqueous solution 
of sodium cyanoborohydride, and left to react overnight. The hmC was precipitated by 
raising the pH of the mixture to around 10. The precipitate was purified by multiple 
washes of ethanol and water, and then dried to a powder. 
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Solution Preparation. hmC was dissolved in 0.04 M acetic acid solution at various 
concentrations. Sodium chloride was then added at a concentration of 0.9% w/v for 
osmotic balance.  The bovine blood was diluted (10) with normal saline.  
 
Cell Suspension Preparation. ATCC L-929 mouse fibroblasts were cultured in Eagle’s 
MEM media supplemented with 5% FBS, 50 IU/mL penicillin, and 0.05 mg/mL 
streptomycin.  Cells were harvested, pelleted by centrifugation, and resuspended to give a 
cell concentration of approximately 2  107 cells/mL in normal saline.   
 
Optical Microscopy. To prepare a sample for microscopic observation, 20 µL of the 
hmC solution was pipetted onto a glass slide.  20 µL of 10 diluted blood was then 
added. The combined solutions were mechanically mixed with a stirring rod, and a 
coverslip was placed on top of the sample. Samples were then imaged immediately using 
an Olympus IX51 at 100 and 400 magnification.  A Hamamatsu A3472-06 camera was 
used to capture multiple micrographs for each sample.   
 
Image Analysis. Clustering in the samples was analyzed using the ImageJ program.  
Images were thresholded and subjected to the ImageJ particle analyzer function. The 
sizes of all clusters greater than 48 µm2 was recorded for each sample. For a given 
sample, several parameters were calculated to obtain an estimate for the extent of 
clustering, including the average size of the ten largest clusters, and the fraction of the 
image area occupied by the ten largest clusters.  
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3.3 Results and Discussion 
 
We performed experiments with bovine blood that has been treated with sodium 
citrate, which is a known inhibitor of the clotting cascade. The elimination of any 
interference from the clotting cascade is important for our experiments. Another inhibitor 
of blood clotting is the biopolymer, heparin. As demonstrated previously, hmC can gel 
both citrated as well as heparinized blood. This implies that gelation has no connection to 
the clotting cascade. Here, we chose to use citrated blood for all our experiments. One 
reason for this is that heparin is a highly negatively charged macromolecule that can 
interact via electrostatic interactions with chitosan as well as hmC, which are both 
cationic polymers. Thus, by using citrated blood we avoid some complications due to 
electrostatic effects, which makes our results cleaner and easier to interpret. 
  
The protocol for our microscopic studies involves combining 20 µL of hmC 
solution with 20 µL of citrated blood on a microscope slide, quickly mixing the two on 
the slide, and observing immediately by bright-field microscopy. In the hmC solution, we 
included 0.9% wt/vol of NaCl for osmotic balance with blood cells. This is important to 
ensure that the blood cells do not suffer any osmotic shock upon mixing with the hmC 
solution. With regard to the blood, we diluted the original stock solution by 10 in 
normal saline. This was done because we found that at the original concentration, the 
density of blood cells was too high within the microscopic field of view, which made it 
difficult to distinguish if the cells were lying on top of each other or undergoing 




Figure 3.1  Interactions of citrated bovine blood with 0.05 wt% chitosan (a) and hmC (b). 
The hmC has C12 hydrophobes with the degree of modification being 5 mol%. Scale bars 
are 100 µm.   
 
 
Figure 3.1 shows representative images at 100 magnification of a mixture of the 
above blood with 0.05 wt% hmC or chitosan. These two images illustrate the key 
difference between the two polymers. In the case of chitosan, the blood cells are mostly 
discrete structures (Figure 3.1a). There seem to be a few small clusters of cells, although 
it is not clear if these are truly clusters (i.e., cells that are adhered to one another) or if the 
cells are simply overlapping at the same spot in the image, but unconnected to each other. 
In comparison, the majority of cells in the hmC case are clustered (Figure 3.1b). The 
clusters are dense structures and consequently appear dark in the image. Also, note that 
because much of the cells are in clusters, there is a lot of “empty” space in the image 
where no cells are seen. Thus, we infer that hmC induces blood cells to cluster, while 
chitosan does not. A closer look at the blood cell clusters induced by hmC is shown in the 
two images of Figure 3.2. It is evident that the clusters are dense aggregates of the cells. 
The individual clusters each have an area of more than 3000 µm2 and their shape is 
(a) Chitosan (b) hmC 
 20 
irregular. Also, note that there is no obvious disruption or hemolysis of the cells, i.e., all 




Figure 3.2  Close-ups (400 magnification) of blood cell clusters formed by combining 




Figure 3.3 Interactions of L-929 mouse fibroblast cells with 0.05 wt% chitosan (a) and 
hmC (C12, 5 mol%) (b). Scale bars are 400 µm.  
 
 
Similar results were also obtained with cells other than blood. For example, we 
studied L-929 mouse fibroblast cells, which were resuspended at a concentration of about 
(a) Chitosan (b) hmC 
(b) (a) 
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2  107 cells/mL in normal saline. This cell suspension was combined with 0.05 wt% 
hmC or unmodified chitosan. We again observe that the cells remain as discrete 
structures when combined with chitosan (Figure 3.3a) whereas they are aggregated into 

























Figure 3.4  Analysis of the images in Figure 3.1 showing the interaction of bovine blood 
with 0.05 wt% chitosan and hmC.  (A) and (B) are thresholded versions of Figure 3.1a 
and 3.1b, respectively. The 10 largest clusters in these images are identified. (3) and (4) 
are the same images after removing the 10 largeest clusters. Note that (C) seems nearly 
identical to (A), whereas (D) is very different from (C). That is, the 10 largest clusters 
occupy only ~ 5% of the total area in Figure 3.1a whereas they occupy ~ 62% of the area 
in Figure 3.1b.  
 
Before proceeding further, we discuss measures to quantify the differences 
between images of clustered and unclustered cells, such as in Figure 3.1. We used the 
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ImageJ software to perform the requisite calculations. The software can threshold the 
image and identify the outlines of all “clusters” (defined as those of size > 48 µm2, which 
is the approximate area of a single RBC) and thereby also make a cluster size 
distribution. However, as noted above, it is not clear in the case of the chitosan sample 
whether the structures identified are indeed clusters or if the cells are merely overlapping. 
For this reason, measures such as the fraction of cells in clusters or the average sizes of 
clusters were not reliable.  
 
The procedure we chose to use is depicted in Figure 3.4. First, we threshold the 
image and identify the 10 largest clusters using ImageJ. The 10 largest clusters in Figure 
3.1a and 3.1b (in decreasing order of size) are numbered in (A) and (B) of Figure 3.4. 
Next, we show the same fields of view in (C) and (D) after the 10 clusters are removed. 
Note that (D) looks very different from (B) because the 10 clusters occupied a large 
fraction of the area in (B), whereas (C) and (A) look about the same because the 10 
clusters were a small fraction of the area. This tells us that the total area of the 10 largest 
clusters is one measure for quantifying the extent of clustering. We normalize this area by 
the total area occupied by all the cells/clusters in the image. The same procedure is 
repeated for 3 images from the same sample. The average and standard deviation are thus 
computed for the normalized areal fraction (%) of the 10 largest clusters. For the images 
in Figure 3.1, we calculate this area to be 5 ± 3% for blood + chitosan (Figure 3.1a) 
whereas it is substantially higher at 62 ± 2% for blood + hmC (Figure 3.1b).  
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Figure 3.5 Effect of varying the degree of modification by C12 hydrophobes. Images are 
for citrated bovine blood combined with 0.05 wt% of hmC containing different mol% of 
C12 hydrophobes: (a) 0.5%; (b) 1%; (c) 2%; (d) 5%. Scale bars are 100 µm.  
 
 
Figure 3.6 From the images in Figure 3.5, the areal fraction (%) of the 10 largest clusters 
is plotted against the degree of modification by C12 hydrophobes. 
(a) 0.5% C12 
(d) 5% C12 (c) 2% C12 
(b) 1% C12 
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We now describe the effects of different variables on blood-cell clustering. First is 
the degree of hydrophobe modification, with the hydrophobe length maintained at C12. 
We compared hmC variants with different degrees of C12 hydrophobes (0.5, 1, 2, and 5 
mol% relative to the amine groups) with blood at a polymer concentration of 0.05 wt%. 
Figure 3.5 shows a systematic trend in the images, with the extent of blood-cell clustering 
increasing with the mol% of hydrophobes, i.e., the more the hydrophobes, the more the 
clustering. These images were quantified by the procedure described above, and the 
results for the areal fraction of the 10 largest clusters are presented in Figure 3.6. This 




Figure 3.7 Effect of varying the length of hydrophobes. Images are for citrated bovine 
blood combined with 0.05 wt% of hmC containing different lengths of hydrophobes (5 
mol% modification): (a) C6; (b) C8; (c) C10; (d) C12. Scale bars are 100 µm.  
(a) C6 (b) C8 





Figure 3.8 From the images in Figure 3.7, the areal fraction (%) of the 10 largest clusters 
is plotted against the hydrophobe length. 
 
 
Next, we tested n-alkyl hydrophobes of different lengths (C6, C8, C10, C12). 
Different varieties of hmC with each of these hydrophobes were synthesized, with the 
degree of modification kept constant at 5 mol% relative to the amine groups. The 
different polymers were tested with blood at a polymer concentration of 0.05 wt%. 
Figure 3.7 again shows a systematic trend in the images, with clustering increasing with 
the length of hydrophobes. From these images, the areal fractions of the 10 largest 
clusters were extracted, and as expected, it increases monotonically with hydrophobe 






Figure 3.9 Effect of hmC concentration. Images are for citrated bovine blood combined 
with hmC (C12, 5 mol%) at different concentrations: (a) 5 10
-5 wt%; (b) 5 10-4 wt%; (c) 
5 10-3 wt%; (d) 5 10-2 wt%. Scale bars are 100 µm.  
 
 
Figure 3.10 From the images in Figure 3.9, the areal fraction (%) of the 10 largest 
clusters is plotted against the hmC concentration. 
(a) 5 x 10-5 wt% 
(d) 0.05 wt% (c) 5 x 10-3 wt% 
(b) 5 x 10-4 wt% 
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Next, we examined different concentrations of an hmC with 5 mol% of C12 
hydrophobes. The images in Figure 3.9 show that clustering occurs at hmC 
concentrations as low as 5  10-4 wt%. Moreover, the extent of clustering, in terms of the 
areal fractions of the 10 largest clusters, was indistinguishable for concentrations between 
5  10-4 and 0.05 wt% (i.e., over two orders of magnitude). Thus, for a strongly clustering 
polymer like the hmC tested here (with a large number of long hydrophoobes), there 









Figure 3.11 Effect of hmC molecular weight. Images are for citrated bovine blood 
combined with 0.05 wt% of hmC (C12, 5 mol%) at two different molecular weights: 
(a) 100 kDa; and (b) 250 kDa. Scale bars are 100 µm.  
 
 
The molecular weight (MW) of the hmC was also tested as an additional 
parameter. The polymers studied thus far had a molecular weight of 250 kDa. For 
comparison, we obtained a lower MW of chitosan, i.e., 100 kDa, and converted this to an 
hmC with 5 mol% of C12 hydrophobes. The two polymers were combined with blood at a 
concentration of 0.05 wt%. Figure 3.11 shows that the clustering in the case of the 
100 kDa polymer is lower than in the case of the 250 kDa polymer. The areal fraction of 
(a) MW = 100 kDa (b) MW = 250 kDa 
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the 10 largest clusters was 22 ± 3% for the 100 kDa hmC compared to 62 ± 2% for the 
250 kDa hmC. 
 
(a) Control: Saline added
(b)α-CD after (c) α-CD before
 
 
Figure 3.12 Effect of -CD on the clustering of citrated bovine blood cells due to hmC 
(C12, 5 mol%). (a) Control case: blood combined with hmC, then saline is added. (b) 
Blood combined with hmC, afterwards -CD is added. (c) hmC is first combined with 
-CD, then the mixture is combined with blood. In all three samples, the hmC 
concentration is the same (0.033 wt%), while in (b) and (c), the -CD concentration is 
the same (16.7 mM). Scale bars are 100 µm.   
 
 
We now examine whether clustering can be reversed by adding CDs. Specifically, 
the type of CD that was shown to reverse gelation of blood (or vesicles) in past studies 
was -CD. Our first experiment involved mixing 20 µL each of blood and hmC solution 
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on the microscope slide (causing cells to cluster), and thereafter adding 20 µL of -CD 
solution. As a control, we substituted the -CD solution with saline, and the result for 
this case (blood + 0.033 wt% hmC) is shown in Figure 3.12a. As expected, we see 
significant clustering. Next, Figure 3.12b shows an image of the sample with added 
16.7 mM of -CD. In this case, we see that the -CD substantially reduces (but does not 
eliminate) the clustering. Interestingly, the order of addition makes a difference. We 
repeated the above experiment by first pre-mixing the hmC solution with the -CD and 
then adding this combination to blood (final sample has same concentrations of hmC and 
-CD). In this case, the clustering is almost eliminated, as shown in Figure 3.12c.    
 
 
Figure 3.13 Effects of m-CD (a) and hp-CD (b) on the clustering of citrated bovine 
blood cells due to hmC (C12, 5 mol%). In these experiments, hmC was first combined 
with the CD, and then the mixture was combined with blood. The hmC concentration in 
the two samples is 0.033 wt% while the CD concentration in each case is 16.7 mM. Scale 
bars are 100 µm. 
 
 
We also compared other types of CDs for their ability to eliminate blood cell 
clustering. Results for two derivatives of -CD, i.e., m-CD and hp-CD, are shown in 
Figure 3.13. In these experiments, the CD was premixed with the hmC and then added to 
(a) m-CD (b) hp-CD 
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blood (same conditions as in Figure 3.12c). We note that both CDs reduce the clustering 
compared to that in the control (Figure 3.12a), but many clusters still do exist. Thus, 
neither of these CDs is as effective as -CD in terms of eliminating clustering. 
 
The experiments thus far have shown that hmC induces clustering of blood cells, 
with the clustering increasing with polymer MW and concentration, as well as with 
hydrophobe density and length. In addition, CDs, and in particular -CD, reduce or 
eliminate the clustering. We can thus make a direct correlation between the clustering 
observed in our microscopic experiments and the gelation seen in macroscopic 
rheological experiments. Similarly the reversal of clustering by the CDs in the 
microscopic images corresponds to the reversal of gelation in the macroscopic studies.  
 
Note that the microscopic experiments here have been done with diluted samples 
relative to those for which gelation is seen. Specifically, the blood cell density is diluted 
10 relative to the original. Also, typical hmC concentrations for gelation with blood are 
about 0.25 to 0.5 wt% (in the case of an hmC with 5 mol% of C12 hydrophobes), which is 
2 to 5 the concentrations studied here. As mentioned, direct microscopic studies are 
difficult for non-diluted samples because the high cell density obscures the field of view. 
Nevertheless, it is reasonable to conclude that clustering in a dilute mixture of hmC and 
blood goes hand-in-hand with gelation in more concentrated mixtures. In our images, the 
clusters are discrete; while such clustering will increase the sample viscosity, it will not 
lead to elastic rheology. Conversely, gelation will occur when a network of clusters is 
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formed that spans the entire sample volume. Such a network will respond as a single unit 
and in an elastic fashion at low deformations, thereby giving rise to a gel-like response.  






















Figure 3.14 Proposed revised mechanism of gelation of hm-chitosan and blood mixtures.  
Hydrophobes insert into the membranes of red cells, white cells, and platelets, forming 
clusters which crosslink the polymer chains thus forming a gel.  Hydrophobes also 
interact with other hydrophobes, further crosslinking the network.  
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Based on our results, we can propose a modified schematic representation for the 
microstructure of a blood/hmC gel. This is shown in Figure 3.14 and is to be compared 
with the schematic proposed earlier and shown in Figure 2.2b. In the new schematic, we 
envision the network as arising from cluster-cluster aggregation. In the colloid literature, 
there are models for diffusion-limited cluster-cluster aggregation, which lead to network 
structures that are rather similar to the above.39,40 The key point here is that hmC seems to 
induce rather dense clusters of blood cells, as shown by our microscopic images. Such 
clusters are evidently formed by hydrophobic interactions, which is why the extent of 
clustering increases with hydrophobe length and density. We speculate that such clusters 
will serve as the nodes of a polymer/cell network. In our earlier mechanism, we had 
omitted such clusters and envisioned individual cells as the network nodes,10 but this does 
not seem realistic based on our new data.  
 
One other element that is reflected in our new schematic is the presence of 
hydrophobic associations between adjacent hmC chains. Such hydrophobic associations 
are usually thought to be transient structures. However, if their lifetimes are sufficiently 
high, they could contribute as additional crosslinks in the network. The reason for 
invoking these polymer-polymer interactions is two-fold. First, we observe that the 
addition of salt can significantly increase the viscosity of an hmC solution. This increase 
is evidently due to polymer-polymer hydrophobic interactions. Note that in the absence 
of salt, the polymer chains would experience significant electrostatic repulsions; 
however, salt ions screen these repulsions and allow the hydrophobes to interact with one 
another. Since salt is always present in blood plasma, its effect cannot be ignored. The 
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second issue has to do with the geometry of the system. For gelation to occur, the volume 
fraction of the cells must be such that the cells fill up the entire volume. However, if 
dense clusters are formed, the volume fraction is reduced and can be far from close-
packing. In such a scenario, the polymer-polymer interactions can still contribute to the 
creation of a volume-filling network, as indicated in macroscopic experiments. 
 
3.4 Conclusions 
This work clearly demonstrates that hmC causes significant clustering and 
aggregation of the blood cells, which is not the case with chitosan.  We have also 
demonstrated that the level of hydrophobic modification has a strong effect on the level 
of clustering observed.  Higher levels of hydrophobic modification lead to higher levels 
of clustering.  We have also shown the length of the hydrophobic group grafted onto the 
chitosan back bone plays a significant role in clustering.  Chitosan modified with longer, 
more hydrophobic groups produced stronger clustering than short hydrophobes.   
 
With respect to -CD, we have shown that the introduction of -CD can disrupt 
clustering almost completely.  We also demonstrated that other cyclodextrins have a 
similar effect.  Finally, we demonstrated a slight difference based on the order of addition 
of -CD, in which -CD introduced after clusters had already formed resulted in a small 
amount of clustering remaining in the sample.  
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Chapter 4: CONCLUSIONS & RECOMMENDATIONS 
 
4.1 Conclusions 
The motivation for this work was to further elucidate the mechanism of gelation 
between hmC and blood.  In this work, we have utilized optical microscopy to observe 
and examine a dramatic difference in the clustering of blood cells when they are exposed 
to hmC compared to unmodified chitosan.  To account for this clustering effect, we 
suggest a revision to the mechanism for the interaction of blood cells and hmC.  This 
mechanism is one in which blood cells are found in clustered groups as opposed to 
singly, and where hydrophobe-hydrophobe interactions dominate in the space between 
adjacent clusters.  In light of these conclusions, we describe a number of additional 
experiments to further elucidate the mechanism of gelation of hmC with blood and 
further explain the clustering observed in this thesis, as described below.  
 
4.2 Future Directions 
 
Chitosanase.  One interesting avenue to pursue in continuing this line of research would 
be to investigate the effect of the enzyme chitosanase on the clustering observed between 
hm-chitosan and blood.  Chitosanase is an enzyme that breaks down the chitosan polymer 
backbone.  It is possible that by adding chitosanase into a sample containing clustered 
blood cells (due to the presence of hmC), the chitosanase will break down the hmC 
polymer and thereby decluster the blood cells.  If this is the case, it would also be 
interesting to determine the minimum amount of chitosanase required for declustering.   
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Fluorescence. Another possible avenue to pursue would be to fluorescently label hmC 
with fluorescein groups.  It is also possible to stain the membranes of red blood cells 
using lipid soluble dye such as Nile Red.  This makes possible a wide range of 
experiments for further investigating the interaction between blood and hmC.  For 
example, if both the blood cells and chitosan were labeled, confocal microscopy could be 
used to create a 3-D image of the hmC blood cell clusters.  From these images, it could be 
determined where the hmC is relative to the blood cells.  
 
Calcium Chloride.  Sodium citrate was used in this study as an anticoagulant to prevent 
the blood from clotting due to the natural clotting cascade.  Citrate works as an 
anticoagulant by chelating the calcium in blood.  Since calcium is essential to natural 
clotting, chelating the calcium prevents clot formation.  However, if additional calcium is 
added in to citrated blood, the chelation due to citrate is overloaded, and the extra 
calcium allows the natural clotting cascade to begin.   
 
 It would be interesting to use microscopy to observe blood cells that are clotted 
naturally.  This could be done with whole blood, and also with diluted blood similar to 
what was used in this study.  It is not certain that diluted blood would clot naturally, as all 
clotting factors would be diluted.  However, it may be possible to resolve this by diluting 
blood using blood plasma as the diluent, which would preserve the concentrations of 
naturally clotting factors while still reducing the number of blood cells present in a 
sample.   
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 With micrographs of naturally clotted blood, we could compare the images to 
those in this study with clustered blood cells due to the presence of hmC.  It would be 
interesting to see if clusters are present in naturally clotted blood.  If there are indeed 
clusters present, it would be interesting to do image analysis on those clusters and see 
how they compare to the clusters formed by hmC.  
 
Time-Based Observations.  As it has been previously indicated that chitosan can cluster 
blood cells over time, we recommend time based observations of all samples tested in 
this thesis.  Samples of chitosan and hmC should be mixed with blood and observed at 
different time points up to at least two hours, as this was the time reported by Evans and 
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